KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $78,054 | -52.4% | 22,957 | -37.0% | 0.00% | -50.0% |
| Q2 2022 | $164,000 | -1.8% | 36,455 | +60.4% | 0.01% | +14.3% |
| Q1 2022 | $167,000 | -50.4% | 22,727 | -56.6% | 0.01% | -41.7% |
| Q4 2021 | $337,000 | -21.1% | 52,402 | -28.5% | 0.01% | -7.7% |
| Q3 2021 | $427,000 | – | 73,295 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 999,275 | $37,403,000 | 55.08% |
| New Leaf Venture Partners, L.L.C. | 126,687 | $4,742,000 | 2.31% |
| Cormorant Asset Management, LP | 385,000 | $14,411,000 | 2.22% |
| SECTORAL ASSET MANAGEMENT INC | 529,920 | $19,835,000 | 0.89% |
| PFM Health Sciences, LP | 850,337 | $31,828,000 | 0.74% |
| Partner Investment Management, L.P. | 16,399 | $614,000 | 0.25% |
| Tekla Capital Management LLC | 137,766 | $5,157,000 | 0.24% |
| Candriam S.C.A. | 298,000 | $11,154,000 | 0.23% |
| Eventide Asset Management | 30,000 | $1,123,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 81,047 | $3,034,000 | 0.12% |